Zhang Lab

University of Michigan

Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only

Online Services

●I-TASSER ●I-TASSER-MTD ●C-I-TASSER ●CR-I-TASSER ●QUARK ●C-QUARK ●LOMETS ●MUSTER ●CEthreader ●SEGMER ●DeepFold ●DeepFoldRNA ●FoldDesign ●COFACTOR ●COACH ●MetaGO ●TripletGO ●IonCom ●FG-MD ●ModRefiner ●REMO ●DEMO ●DEMO-EM ●SPRING ●COTH ●Threpp ●PEPPI ●BSpred ●ANGLOR ●EDock ●BSP-SLIM ●SAXSTER ●FUpred ●ThreaDom ●ThreaDomEx ●EvoDesign ●BindProf ●BindProfX ●SSIPe ●GPCR-I-TASSER ●MAGELLAN ●ResQ ●STRUM ●DAMpred

●TM-score ●TM-align ●US-align ●MM-align ●RNA-align ●NW-align ●LS-align ●EDTSurf ●MVP ●MVP-Fit ●SPICKER ●HAAD ●PSSpred ●3DRobot ●MR-REX ●I-TASSER-MR ●SVMSEQ ●NeBcon ●ResPRE ●TripletRes ●DeepPotential ●WDL-RF ●ATPbind ●DockRMSD ●DeepMSA ●FASPR ●EM-Refiner ●GPU-I-TASSER

●BioLiP ●E. coli ●GLASS ●GPCR-HGmod ●GPCR-RD ●GPCR-EXP ●Tara-3D ●TM-fold ●DECOYS ●POTENTIAL ●RW/RWplus ●EvoEF ●HPSF ●THE-DB ●ADDRESS ●Alpaca-Antibody ●CASP7 ●CASP8 ●CASP9 ●CASP10 ●CASP11 ●CASP12 ●CASP13 ●CASP14

GLASS

You can:

Go to the GPCR, ligand, or experimental data tables.
Go to the experimental data table for text mining information in PubMed ID column.
Go to the GPCR page and check other ligands which interact with it.
Go to the ligand page and check other GPCRs which it interacts with.
Go back to previous page.

GPCR

Name	5-hydroxytryptamine receptor 1B
Species	Rattus norvegicus (Rat)
Gene	Htr1b
Synonym	HTR1D2 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled 5-HT1Dbeta 5-HT1DB 5-HT1B serotonin receptor 5-HT1B receptor 5-HT1B 5-HT-1B Serotonin receptor 1B [ Show all ]
Disease	N/A for non-human GPCRs
Length	386
Amino acid sequence	MEEQGIQCAPPPPATSQTGVPLANLSHNCSADDYIYQDSIALPWKVLLVALLALITLATTLSNAFVIATVYRTRKLHTPANYLIASLAVTDLLVSILVMPISTMYTVTGRWTLGQVVCDFWLSSDITCCTASIMHLCVIALDRYWAITDAVDYSAKRTPKRAAIMIVLVWVFSISISLPPFFWRQAKAEEEVLDCFVNTDHVLYTVYSTVGAFYLPTLLLIALYGRIYVEARSRILKQTPNKTGKRLTRAQLITDSPGSTSSVTSINSRVPEVPSESGSPVYVNQVKVRVSDALLEKKKLMAARERKATKTLGIILGAFIVCWLPFFIISLVMPICKDACWFHMAIFDFFNWLGYLNSLINPIIYTMSNEDFKQAFHKLIRFKCTG
UniProt	P28564
Protein Data Bank	N/A
GPCR-HGmod model	N/A
3D structure model	No available structures or models
BioLiP	N/A
Therapeutic Target Database	N/A
ChEMBL	CHEMBL3459
IUPHAR	2
DrugBank	N/A

Ligand

Name	doxorubicin
Molecular formula	C27H29NO11
IUPAC name	(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
Molecular weight	543.525
Hydrogen bond acceptor	12
Hydrogen bond donor	6
XlogP	1.3
Synonyms	Rubex (TN) 13171-EP2308839A1 CHEBI:28748 10336-EP2298748A2 UNII-80168379AG 14-Hydroxydaunorubicine D07VLY 10336-EP2301928A1 25316-40-9 (hydrochloride) Doxorubicin (USAN/INN) 10336-EP2305671A1 AB1009243 Doxorubicin-P4/D10 conjugate 10336-EP2311453A1 (1s,3s)-3,5,12-Trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranoside; Adriamycin; Doxorubicin EINECS 245-495-6 10336-EP2316452A1 ADR (7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride HY-15142A 13171-EP2270008A1 Adriamycin PFS (hydrochloride salt) (8S-cis)-10-(3-Amino-2,3,6-Tr ideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione MCULE-4188577717 13171-EP2289892A1 Adriblastina 10336-EP2270018A1 NCGC00024415-40 13171-EP2295413A1 BDBM22984 10336-EP2277568A2 Prestwick2_000438 13171-EP2298780A1 C-23275 10336-EP2292280A1 Caelyx (liposomal doxorubicin) 10336-EP2292617A1 SMP1_000106 13171-EP2316832A1 cid_443939 10336-EP2298768A1 23214-92-8 DM2 10336-EP2302383A2 45970-EP2287156A1 Doxorubicin [USAN:INN:BAN] 10336-EP2308562A2 Doxorubicine 10336-EP2311825A1 (7S,9R)-7-[(2S,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione FT-0601614 10336-EP2316834A1 adriablastine (hydrochloride salt) (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydroxydaunorubicin 13171-EP2275102A1 Adriamycin RDF (hydrochloride salt) 1,2,3,4,6,11-Hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6,11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranoside Myocet 13171-EP2292614A1 adriblatina (hydrochloride salt) 10336-EP2272832A1 NCI-C01514 13171-EP2298736A1 BPBio1_000502 10336-EP2277865A1 Probes2_000129 13171-EP2305642A2 13171-EP2305689A1 CC-23807 10336-EP2295426A1 TLC D-99 13171-EP2316937A1 CS-2759 10336-EP2301536A1 25311-50-6 Doxil 10336-EP2305640A2 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- Doxorubicin-hLL1 conjugate 10336-EP2308855A1 (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside Doxorubicinum [INN-Latin] 10336-EP2311840A1 adiblastine (hydrochloride salt) (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione HMS2089H06 13171-EP2269989A1 Adriamycin (8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione LMPK13050001 13171-EP2281815A1 Adriblas tina 10336-EP2270008A1 NCGC00024415-37 13171-EP2295407A1 AN-17965 10336-EP2277566A2 Prestwick0_000438 13171-EP2298768A1 BSPBio_000456 10336-EP2281815A1 Rubex 10336-EP2292614A1 SB21799 13171-EP2308861A1 10336-EP2298764A1 ZINC3918087 14D928 D0VW5S 10336-EP2301933A1 29042-30-6 Doxorubicin citrate 10336-EP2305679A1 Doxorubicina 10336-EP2311455A1 (1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-L-lyxo-hexopyranosid) Farmablastina (hydrochloride salt) 10336-EP2316832A1 adr iablatina (hydrochloride salt) (7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride Hydroxydaunomycin hydrochlor ide (hydrochloride salt) 13171-EP2270018A1 Adriamycin PFS (TN) (8S-cis)-10-(3-Amino-2,3,6-Trideoxy-alpha-L-Lyxo-Hexopyranosyl)Oxy-7,8,9,10-Tetrahydro-6,8,11-Trihydroxy-8-(Hydroxyacetyl)-1-Methoxy-5,12-Naphthacenedione MLS000028393 13171-EP2292227A2 Adriblastina (hydrochloride salt) 10336-EP2270505A1 NCGC00024415-41 13171-EP2295416A2 BDBM32022 10336-EP2277569A2 Prestwick3_000438 13171-EP2301933A1 C01661 Caelyx (TN) 10336-EP2295055A2 SPBio_002395 13171-EP2316833A1 Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74 10336-EP2298778A1 23257-17-2 DOX 10336-EP2305243A1 45970-EP2311807A1 Doxorubicin(Adriamycin) 10336-EP2308812A2 Doxorubicine [INN-French] 10336-EP2311827A1 AC1L1M5T (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione GR-319 10336-EP2371811A2 adriablatina (hydrochloride salt) (8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydroxydaunorubicin hydrochloride (hydrochloride salt) 13171-EP2277865A1 Adriamycin RDF (TN) 10-((3-Amino-2,3,6-trideoxy-alpha-L-lyso-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione Myocet (TN) 13171-EP2292615A1 Aerosolized Doxorubicin 10336-EP2275420A1 NDC 38242-874 13171-EP2298746A1 BRD-K92093830-003-04-3 10336-EP2277876A1 RDF Rubex 13171-EP2305671A1 Rubex (hydrochloride salt) 13171-EP2308833A2 CCRIS 739 10336-EP2295427A1 Triferric doxorubicin 14-Hydroxydaunomycin D03899 10336-EP2301538A1 25316-40-9 10336-EP2305642A2 80168379AG Doxorubicin-P4/D10 10336-EP2308861A1 (1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside DTXSID8021480 10336-EP2311842A2 ADM (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride HSDB 3070 13171-EP2269994A1 Adriamycin PFS (8S-cis)-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione LS-165655 13171-EP2286812A1 Adriblastin 10336-EP2270014A1 NCGC00024415-38 13171-EP2295412A1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 10336-EP2277567A1 Prestwick1_000438 13171-EP2298772A1 BSPBio_001031 10336-EP2289892A1 10336-EP2292615A1 SCHEMBL3243 13171-EP2311827A1 CHEMBL53463 10336-EP2298765A1 DB00997 10336-EP2302382A2 45970-EP2275413A1 Doxorubicin hydrochloride (hydrochloride salt) 10336-EP2305689A1 Doxorubicina [INN-Spanish] 10336-EP2311808A1 (1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside FI 106 10336-EP2316833A1 Adriablastin (8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracen Hydroxydaunomycin hydrochloride (hydrochloride salt) 13171-EP2270505A1 Adriamycin RDF (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione MolPort-006-124-025 13171-EP2292233A2 Adriblastina (TN) 10336-EP2272827A1 NCGC00024415-42 13171-EP2298305A1 BP-23114 10336-EP2277570A2 Probes1_000151 13171-EP2305640A2 Caelyx 13171-EP2305679A1 Cantide + adriamycin 10336-EP2295416A2 ThermoDox 13171-EP2316834A1 Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120 10336-EP2298780A1 24385-08-8 DOX-SL 10336-EP2305250A1 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)- Doxorubicin-hLL1 10336-EP2308833A2 Doxorubicinum 10336-EP2311829A1 AC1Q29OJ (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride GTPL7069 10336-EP2374454A1 Adriacin (hydrochloride salt) (8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione JT9100000 13171-EP2277876A1 Adriamycin semiquinone 10-((3-Amino-2,3,6-trideoxy-D-lyxohexopyranosyl)oxy)-8-glycolcyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione NCGC00024415-35 13171-EP2292617A1 AKOS015951330 10336-EP2277565A2 NSC 123127 13171-EP2298748A2 BRD-K92093830-003-25-8 10336-EP2280012A2 Resmycin [ Show all ]
Inchi Key	AOJJSUZBOXZQNB-TZSSRYMLSA-N
Inchi ID	InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1
PubChem CID	31703
ChEMBL	CHEMBL53463
IUPHAR	N/A
BindingDB	22984
DrugBank	N/A
Structure SDF download
Lipinski's druglikeness	This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons.

Experimental Data

Parameter	Value	Reference	Database source
IC50	34464.0 nM	DrugMatrix in vitro pharmacology data	ChEMBL
Ki	15666.0 nM	DrugMatrix in vitro pharmacology data	ChEMBL

yangzhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218